Cytori CEO Calhoun on Stem Cell Therapies, Contract
Sept. 28 (Bloomberg) -- Christopher Calhoun, chief executive officer of Cytori Therapeutics Inc., talks about the company's $4.7 million contract with the U.S. government to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs. The contract may be worth $106 million over five years if certain milestones are met. Calhoun speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Most Recent Videos
BlackRock’s Rodriguez Says Mexico a Strong Ally of U.S.
43:29 - Gerardo Rodriguez, managing director for emerging markets at BlackRock, discusses U.S.-Mexico trade relations and possible outcome from Nafta negotiations. He speaks with Tom Keene and Guy Johnson on "Bloomberg Surveillance." (Source: Bloomberg)